1 paper
Yuansheng Liu, Yufei Ye, Tao Tang +3
Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative therapeutic strategy that selectively degrades historically ''undruggable'' targets via the ubiquitin-prot…